Introduction: Hypertension is a modern epidemic. Dyslipidemia with hypertension increase cardiovascular morbidity by many folds. Abnormal lipoprotein profile itself associated with raised blood pressure. The study was conducted to find out the proportion of dyslipidemia and any association between the different components of blood lipids with hypertension. Methodology: It was a cross sectional study conducted in rural area of Nagpur among 574 adult subjects. Biochemical investigation was undertaken among 110 subsample and statistical tests were conducted with the help of SPSS software, version 19.0. Results: Prevalence of hypertension and dyslipidemia was 17.9% and 83.63% respectively. Positive correlation was found between SBP and Cholesterol, LDL-C. Conclusion: Regular screening for blood pressure and lipoprotein profile in community and adequate management will have beneficial role in prevention of development of early cardiovascular disorders in population.
BACKGROUND One of the most common clinical conditions in ophthalmology practice is dry eyes. It has been documented in various research studies that corneal surgeries including clear corneal Phacoemulsification plays a significant role in the development of dry eyes. This is largely attributable to the injuries suffered by the corneal nerves and corneal surface alteration. The purpose of the present study is to evaluate the development of dry eye disease after cataract surgery by Phacoemulsification and to study the temporal association of dry eyes and Phacoemulsification. MATERIALS AND METHODS The present study was a prospective, single centre, randomized one conducted in the department of Ophthalmology, IQ City Medical College, Durgapur, West Bengal from June 2016 to May 2017. A total of 50 patients were selected from the outpatient department who had undergone uncomplicated clear corneal Phacoemulsification due to senile cataract and who did not have preoperative dry eyes. Dry eye pattern was assessed by Ocular Surface Disease Index (OSDI) score, fluorescein staining and determination of Tear Break up Time (TBUT), corneal and conjunctival fluorescein staining score as per Oxford Schema, and Schirmer Test 1 without anaesthesia (S1T)-all performed in the above consecutive order. Comparison of data was done among mean OSDI score, mean TBUT time and mean ST1 values on 1 st week, 4 th week, and 12 th week against preoperative values. RESULTS A total of 50 eyes of 50 patients were studied. The age group of the patients ranges from 45 years to 85 years. The mean age was 62 ± 10.357. Most of the cases (84%) had shown significant changes in S1T and TBUT values in the first week. Statistically significant difference in TBUT and OSDI score was noted at the end of 1 st week. The values gradually recovered through 4 th week and almost attained the preoperative values at the end of 12 th week. The risk of developing dry eyes was found to be more pronounced in the elderly age group.
In India, the Management Aptitude Test (MAT) score is taken as the primary indicator of a student's ability to be enrolled in the management courses. It has been observed in many cases during the group discussion and personal interview phases for MBA course admission, that candidate with poor MAT scores do well than those with higher scores. Hence, in that context, this research was carried out in order to assess the validity of MAT scores in predicting future success and also to measure the nature and strength of association between MAT scores and academic achievements. We also look at the correlation between students' academic performance in their higher-secondary & under-graduate levels, and their MAT scores.
Background: Thrombophilia is a potentially treatable cause of adverse pregnancy outcome. The objective was to compare the fetomaternal outcome in thrombophilia patients with adverse pregnancy outcome after treating with lowmolecular-weight (LMW)/ unfractionated heparin and aspirin. Methods: 54 antenatal women studied who had an earlier or presenting pregnancy complicated by adverse pregnancy outcome were included in this study. In the present pregnancy, therapy consisting of LMW heparin and aspirin was administered who were found to be thrombophilia positive. Patients also received folic acid supplementation throughout their pregnancy. The fetomaternal outcome is compared according to the time of initiation of treatment. Results: Low-molecular-weight heparin and aspirin was well tolerated and none of the women or the newborns developed any hemorrhagic complications.3 thrombophilia negative cases with history of recurrent pregnancy loss aborted even getting treatment from 1 trimester. 1 thrombophilia positive case with history of recurrent pregnancy loss aborted when received treatment from 2nd trimester. There is 25.8% increase in birth weight of neonate if thrombophilia positive cases were treated from 1st trimester. Whereas there was only 10.23% increase in birth weight in thrombophilia negative cases when treated from first trimester. We found, our treatment was significantly effective in preventing IUD, IUGR, abruption, abortion, eclampsia. Though prevention of PIH had no significant correlation with antithrombotic treatment, only 2 cases booked from 1st trimester developed PIH among thrombophilia positive cases. But neither of cases had suffered from any severe complication as compared to 81% of eclampsia cases, 16.67% of DVT cases, 1 case of mortality in cases treated after third trimester. Conclusions: This case control trial suggests that patients with adverse pregnancy outcome and thrombophilia may get benefit from treatment with combined LMW heparin and aspirin in subsequent pregnancies. We suggest all patients with adverse pregnancy outcome should be investigated for thrombophilia markers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.